FDA Inspection 1143187 — Mark Gotfried, M.D
The FDA completed an inspection of Mark Gotfried, M.D on June 1, 2021 in Glendale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 1, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Glendale, AZ (United States)
Additional Details
Clinical Investigator (CI)